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Introduction
Detailed mechanisms for the development and progression of breast carcinoma
remain largely unknown. However, some key insights are known like the role of
genomic instability, which is believed to be an initiating event in tumorigenesis.
The loss of telomere function is one mechanism of attaining genomic instability.1
Human telomeres are nucleoprotein structures that support chromosome ends and protect
them from being marked as DNA double strand breaks. They aid in preventing genomic
errors that can result in chromosomal degradation, recombination, and genomic
instability.2 Unfortunately, telomeres can become eroded and therefore dysfunctional.
This is a common occurrence in tumors and confers the ability to change genetic and
phenotypic profiles leading to malignant characteristics.3 Previous research has
demonstrated that telomere length and/or telomere DNA content is a predictor of disease
progression in breast carcinoma and other cancers.4
In addition to telomere aberrations, another marker of genomic instability is
allelic imbalance, which is a situation where one allele of a gene pair is lost or amplified.
In this study allelic imbalance was assessed by looking at the ratio of peak heights of
heterozygous loci using a multiplex PCR assay.5 Both forms of genomic instability,
allelic imbalance and telomere attrition, arise in breast tumors and in adjacent
histologically normal tissue.6,7 As a result, it has been hypothesized that within
histologically “normal” breast tissues adjacent to tumors lie a store of pre-malignant, yet
potentially tumorigenic cells.5
Heaphy et al. (from the Griffith/Bisoffi lab) investigated the relationship between
genetic alterations in tumors and matched tumor-adjacent histologically normal (TA-HN)

tissues in two groups of breast cancer. One group included tumor and matched TA-HN
tissue taken at 1cm and 5cm from tumor margins. It was found that the breast tumors
demonstrated properties of the matched TA-HN breast tissue at 1 cm, and there was
conservation of unbalanced alleles in these samples. The average telomere content (TC)
in the TA-HN 5cm and TA-HN 1 cm tissues was 101% and 66% of TC in normal
placental DNA standard, respectively. The average TC of breast tumors was 59%. TC of
the TA-HN 5cm tissue was within the range of normal (non-tumor) tissue. However, TC
of the TA-HN 1cm tissue was significantly less than the normal breast tissue and TA-HN
5cm tissue. Mean TC in tumor and TA-HN 1cm was nearly the same.
The degree of genomic instability in these breast cancer samples was further
analyzed for allelic imbalance (AI) at 16 unlinked microsatellite loci. Results from the
Heaphy et al. study showed that in one group of breast tumors the mean number of
unbalanced loci in the TA-HN 1cm and tumor tissues was 0.42 and 1.25 loci per
specimen, respectively. This was roughly 5 and 15 times higher than the incidence in the
TA-HN 5cm tissues. In a second group of breast tumors the mean numbers of
unbalanced loci in the TA-HN (undefined distance from tumor) tissues and matched
tumors were 2.61 and 2.48 loci per specimen respectively, and they were significantly
higher than normal breast tissue.
These were the first studies to investigate genomic instability at defined distances
of 1cm and 5cm from surgical tumor margins. They found that genomic instability in
these tissues was a function of distance from the tumor margin, and the extent of genomic
instability decreased with increasing distance from the tumor margin. As a result, Heaphy
et al. proposed a hypothesis that breast epithelial carcinogenesis occurs at higher

frequency in fields of cells with increased genomic instability. All together a strong case
for field cancerization was made and supported by this studies.
The aim of this current project was to further explore the extent and spatial
distribution of genomic instability in tissue adjacent to breast tumors based upon the
results of recent Heaphy et al. work which looked at TA-HN tissue in only one direction
at 1cm and 5cm from the margins of tumors. To accomplish this goal, two novel aspects
of a proposed field of cancerization were introduced and investigated. These aspects
were to evaluate genomic instability in more than one direction and at an additional point
of 3cm from the margin of tumors. For the multidirectional aspect of the study one
patient breast tissue sample was used. It consisted of breast tumor, TA-HN breast tissue
taken at 1cm, 3 cm, and 5cm in two directions (perpendicular) away from the tumor
margin, and contralateral normal breast tissue. To define a more precise relationship
between genomic stability as a function of distance from a tumor we looked at six
independent breast cancer tissue samples and their respective TA-HN tissue taken in one
direction at 1, 3, and 5 cm from the margins of breast tumors. Here the novel component
was the addition of a middle point taken in TA-HN tissue at 3cm from a tumor margin.

Methods and Materials
Breast Tissue Samples
As approved by the UNM Human Research Review Committee (HRRC #03-085),
a set of human breast tissue was used in this study. The tissue came from seven women
who underwent mastectomies for breast carcinoma and was provided by the UNM Health
Sciences Center Pathology Laboratory (in collaboration with Nancy Joste, MD and Myra
Zucker, PA). The breast tissue was donated as “remnant material” after pathological
evaluation. Approximately 500mg of tissue was excised from the tumors and sites 1cm,
3cm, and 5cm from the visible tumor margins. Contralateral normal breast tissue was
also excised from one individual for the multidirectional study. This patient tissue set
also had tissues excised in two perpendicular directions from the margin of it’s tumor.
10-12 μm sections of the breast tissue was prepared and stained with hematoxylin and
eosin and examined microscopically to verify histologically normal and tumor tissue.
DNA Isolation and Quantification
DNA from breast tissue samples was isolated using Qiagen DNeasy Tissue kits as
previously described5. The isolated DNA was quantified using Picogreen dsDNA
quantification reagent, an ultra-sensitive nucleic acid stain, and a fluorometer.
Telomere DNA Content (TC) Assay
TC was measured using the slot blot titration assay as previously described.9
Isolated DNA was denatured at 56°C in 0.05 M NaOH/1.5 M NaCl, neutralized in 0.5 M
Tris/1.5 M NaCl, and applied and UV cross-linked to Tropilon-Plus blotting membranes
(Applied Biosystems, Foster City, CA). A telomere-specific oligonucleotide, end-labeled
with fluorescein, (5’-TTAGGG-3’)4-FAM, (IDT, Coralville, IA) was hybridized to the

genomic DNA, and the membranes were washed in wash buffers containing SSC and
SDS of increasing stringency to remove non-hybridizing oligonucleotides. Hybridized
oligonucleotides were detected using an alkaline phosphatase-conjugated anti-fluorescein
antibody that produces light when incubated with the CDP-Star substrate (Applied
Biosystems, Foster City, CA). Blots were exposed to Hyperfilm® for 1-2 min
(Amersham Pharmacia Biotech, Buckinghamshire, UK) and digitized by scanning. The
intensity of the telomere hybridization signal was measured from the digitized images
using Nucleotech Gel Expert Software 4.0 (Nucleotech, San Mateo, CA). TC is
expressed as a percentage of the average chemiluminescent signal of four replicate DNA
samples compared to the same amount of a placental DNA standard.5
Allelic Imbalance (AI) Assay
DNA (approximately 1 ng) was amplified using the AmpFlSTR Identifiler PCR
Amplification Kit (Applied Biosystems, Foster City, CA) using the manufacturer’s
protocol. Each multiplex PCR reaction amplifies 16 unlinked, genome-wide short
tandem repeat (STR) microsatellite loci (Amelogenin, CSF1PO, D2S1338, D3S1358,
D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D19S433, D21S11, FGA,
TH01, TPOX and vWA). Each of the PCR primers were labeled with one of four
fluorescent dyes (6-FAM, PET, VIC and NED), each with a unique emission profile,
allowing the simultaneous resolution of amplicons of 16 similar sizes. PCR products
were resolved by capillary gel electrophoresis and detected using an ABI Prism 377 DNA
Sequencer (Perkin Elmer, Foster City, CA). Data was analyzed using the ABI Prism
GeneScan and Genotype Analysis software (Applied Biosystems, Foster City, CA). The
ratios of peak heights from all were calculated. By convention, the allele with the greater

fluorescence intensity as the numerator was used, and thus the ratio was always ≥ 1.0,
with 1.0 representing the theoretical ratio for normal alleles. Allelic pairs with a ratio of
≥ 1.61 were used as an indication of AI.9
Statistical Analysis
Statistical analysis was performed using the JMP® statistical package (SAS
Institute, Cary, NC) using a significance level of 0.05. The non-parametric
Wilcoxon/Kruskal-Wallis Log Rank test was used to determine the comparative
distribution of TC and AI (markers of genomic instability) in breast tumor and
histologically normal tissues located at 1cm, 3cm, and 5cm from the tumor margins.

Results:
Allelic Imbalance Data: One Multidirectional Breast Sample
Allelic imbalance was measured in one multidirectional breast tissue sample set
consisting of tumor, matched TA-HN taken at 1,3,5cm in two directions from the tumor
margin, and normal contralateral breast tissue. The tumor contained 4 sites of AI. TAHN tissues at all distances also contained sites of AI, although not as many as within the
tumor. There were slightly more sites of AI at 3cm and 5cm in both directions when
compared to 1cm. The contralateral breast tissue had 1 site of AI (Figure 1).
Sample
Tumor
contralateral breast
Dimension 1, 1cm
Dimension 1, 3cm
Dimension 1, 5cm
Dimension 2, 1cm
Dimension 2, 3cm
Dimension 2, 5cm

AI (A)
4
1
1
2
2
0
2
2

AI (B)
0
2
2
2
2
2
2

Figure 1: The table summarizes the number of sites with AI as a function of distance and
direction. The letters A and B represent tissue taken from opposite ends of tissue excised

at each point (1,3,5cm) along the two dimensions from the tumor. The data is shown as a
schematic below the table.
Allelic Imbalance Data: Six Independent Unidirectional Breast Samples
Allelic imbalance was measured in six independent sets of breast
tumors and their TA-HN taken at 1,3,5 cm in one direction from the margins of the
tumors. Mean number of AI for tumors was 3, while all TA-HN tissues were less than 1.
There were statistically significant differences in the mean sites of AI between tumor and
1cm (p=0.0026), 3cm (p=0.0098) and 5cm (p=0.0079) TA-HN tissues. However, there
was no statistically significant difference amongst the TA-HN tissues.
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Figure 2: Number of AI sites in one directional samples. The tumors have more sites of
AI than the TA-HN tissues. T = tumor. 1,3,5cm are TA-HN tissue taken at these
distances. Standard error bars also shown.

Allelic Imbalance Data: Six Independent Unidirectional Breast Samples
Conservation of unbalanced alleles in matched tumor (T) and TA-HN breast
tissues was measured in six independent breast tissue sets A-F. Two tissue sets (D and E)
showed conservation of allelic imbalance in one locus between tumor and TA-HN tissue
as seen in Figure 3.

Figure 3: Conservation of unbalanced alleles in matched tumor (T) and tumor-adjacent
histologically normal (TA-HN) breast tissues. There are six independent breast tissue sets
A-F. Sites of allelic imbalances are indicated by gray boxes; sites of allelic imbalances
conserved between tumor and TA-HN tissues are indicated by black boxes. The unlinked
chromosomal loci are designated 1-15 and are as following (1) D8S1179, (2) D21S11, (3)

D7S820, (4) CSF1PO, (5) D3S1358, (6) TH01, (7) D13S317, (8) D16S539, (9)
D2S1338, (10) D19S433, (11) vWA, (12) TPOX, (13) D18S51, (14) D5S818, (15) FGA.
Note: homozygous amelogenin (all female samples) is not shown.

Telomere Content (TC) Data: One Multidirectional Breast Sample
TC was measured in one multidirectional breast tissue sample set consisting of
tumor, matched TA-HN taken at 1,3,5cm in two directions from the tumor margin, and
normal contralateral breast tissue. TC in all these locations is nearly equivalent as seen in
Figure 4.
Sample
Tumor
contralateral breast
Dimension 1, 1cm
Dimension 1, 3cm
Dimension 1, 5cm
Dimension 2, 1cm
Dimension 2, 3cm
Dimension 2, 5cm

TC (A)
1.09
1.14
1.15
1.14
1.19
1.15
1.15
1.18

TC (B)
1.04
1.06
1.14
1.15
1.02
1.05
1.15

Figure 4: The table summarizes the TC as a function of distance and direction. The center
red is the tumor. The letters A and B represent TA-HN tissue taken from opposite ends of
tissue excised at each point (1,3,5cm) along the two dimensions from the tumor The
smaller outer circle is TC values for the normal tissue contralateral breast. The data is
shown as a schematic below the table.
Telomere Content Data: Six Independent Unidirectional Breast Sample
Telomere content was measured in six independent sets of breast
tumors and their TA-HN taken at 1,3,5 cm in one direction from the margins of the
tumors. The distribution for TC for all tissues significantly overlapped and the p values
between all were greater than 0.05 as seen in Figure 5. Yet, the p-values are not shown in
Figure 5.

Figure 5: Distribution of telomere DNA content (TC) in six independent breast tissue
sets. N= 6 for T(tumor) and TA-HN at 1,3,5cm from tumor. TC is expressed as
percentage of TC in placental control. The boxes represent group median (line across

middle) and quartiles (25th and 75th percentiles) at its ends. Lines below and above
boxes indicate 10th and 90th percentiles.

Conclusion/Discussion:
Genomic Instability is an important event involved in the development and
progression of breast carcinoma. In this current study two quantitative markers of
genomic instability were assessed, telomere content (TC) and allelic imbalance (AI).
Both markers of genomic instability (AI and TC) occur in breast tumors and in adjacent
histologically normal tissue. Therefore, it has been hypothesized that fields of
cancerization or areas of tumorigenic potential exist around tumors.
Heaphy et al. were the first group to investigate genomic instability in TA-HN
breast tissue at defined distances of 1cm and 5cm from surgical tumor margins and hence
within the field affected by cancerization. They concluded that genomic instability in
these tissues was a function of distance from the tumor margin, and the extent of genomic
instability decreased with increasing distance from the tumor margin. However, in their
study only TA-HN breast tissue taken in one direction from a tumor’s margin was
explored. Therefore, the purpose of this current study was to further investigate the
extent and spatial distribution of genomic instability in tumors and their matched TA-HN
tissues by looking in more than one direction and at an additional distance point of 3cm
from a tumor margin.
Originally, I had hypothesized that telomere DNA content (TC) in tumor
adjacent-histologically normal (TA-HN) breast tissues at 1cm, 3cm, and 5cm in more
than one direction from a tumor margin would define a field of increasing TC with

increasing distance from the tumor margin. Similarly, for allelic imbalance (AI) I had
hypothesized that TA-HN 5cm tissue would be significantly different (low extent of AI)
when compared to the 1cm, 3cm, and tumor tissues.
In this study we were able to procure one multidirectional breast tissue sample set
that showed four sites of AI in the tumor TA-HN tissues at all distances (1,3,and 5cm)
also had sites of AI, although not as many as the tumor. This data is consistent with the
fact that there is increased inherent genomic instability within tumors. For this patient
contralateral breast tissue was available and had one site of AI. Overall, this data is not
entirely consistent with what Heaphy et al. had found in previous studies as they showed
AI similarities between tumor and 1cm TA-HN tissues. The telomere content (TC) in
the one multidirectional breast tissue sample set was nearly equivalent in the tumor and
matched TA-HN tissues at all distances (1,3,5cm) from the tumor margin. In addition we
measured in this study was AI in six independent sets of breast tumors and their TA-HN
taken at 1,3,5 cm in one direction from the margins of the tumors. Data from this study
showed that on average tumors had significantly more sites of AI when compared to their
matched TA-HN tissues at any distance from the tumor margin. With regard to the 1cm
distance from the tumor margin, this data does not correlate with previous studies, which
showed AI similarities between tumor and TA-HN at 1 cm. In addition, data from this
current analysis showed no difference in AI in TA-HN tissues at 1,3,and 5cm.
Telomere Content was measured in one multidirectional sample set. There was
no difference in TC between tumor, TA-HN, or contralateral tissues. The same was true
for the six unidirectional breast tumors and TA-HN tissues analyzed in this study. There

was no statistical difference in TC for these tissues. As with AI, these data are not in
agreement with previous studies by Heaphy et al.
There were some major limitations in this study. First, for the multidirectional
study our lab was able to obtain only one breast tissue set from a single patient. As a
result, an accurate comparative analysis of genomic instability in a multidirectional field
around breast tumors was limited and not amenable to statistical assessment. Also, in the
investigation of the six unidirectional breast tissue sets there was considerable variability
in TC values in all samples. In addition, I had to use high standard deviation cutoffs to
include data in this TC analysis study. While this variability could be due to
experimental errors, the overall agreement with our previously reported data was low.
However, despite the limitations of this study, the overall concept of the project is
still worthy of further investigation. There is potentially practical and clinically
important information to be gained. For example, from a surgical perspective it would be
useful to have excision margins that were truly free of any cancerous potential.
Genetically aberrant areas around breast tumors may leave a risk for local recurrence,
which occurs in up to 22% of patients receiving conservative treatment for small invasive
and non-invasive breast cancer.10 The concept of this project aims to complement
standard histology with molecular testing for genomic instability for field cancerized
breast tissue. Consequently, a better understanding as well as detection of areas of
genomic instability in TA-HN breast tissue may allow for better diagnosis, treatments,
and overall survival for patients with breast carcinoma.
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